Login to Pancreatic Cancer UK

Further reading - Development of centralised care

  1. Faluyi, O. O. et al. Advanced pancreatic adenocarcinoma outcomes with transition from devolved to centralised care in a regional Cancer Centre. Br J Cancer 116, 424-431, doi:10.1038/bjc.2016.406 (2017).
  2. Kleeff, J. et al. Pancreatic cancer. Nature Reviews Disease Primers 2, 16022, doi:10.1038/nrdp.2016.22 (2016).
  3. Burris, H. A., 3rd et al. Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. Journal of Clinical Oncology 15, 2403-2413, doi:10.1200/JCO.1997.15.6.2403 (1997).
  4. Garrido-Laguna, I. & Hidalgo, M. Pancreatic cancer: from state-of-the-art treatments to promising novel therapies.Nature Reviews Clinical Oncology 12, 319-334, doi:10.1038/nrclinonc.2015.53 (2015).
  5. Conroy, T. et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. New England Journal of Medicine 364, 1817-1825, doi:10.1056/NEJMoa1011923 (2011).
  6. Moorcraft, S. Y. et al. FOLFIRINOX for locally advanced or metastatic pancreatic ductal adenocarcinoma: The Royal Marsden Experience. Clinical Colorectal Cancer 13, 232-238, doi:10.1016/j.clcc.2014.09.005 (2014).
  7. Taieb, J. et al. What treatment in 2017 for inoperable pancreatic cancers? Annals of Oncol 28, 1473-1483, doi:10.1093/annonc/mdx174 (2017).
  8. Suker, M. et al. FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level metaanalysis. The Lancet Oncology 17, 801-810, doi:10.1016/S1470-2045(16)00172-8 (2016).
  9. Mukherjee, S. et al. Pancreatic cancer within a UK cancer network with special emphasis on locally advanced non-metastatic pancreatic cancer. Clinical Oncology (R Coll Radiol) 20, 535-540, doi:10.1016/j.clon.2008.02.003 (2008).
  10. Sirri, E. et al. Recent trends in survival of patients with pancreatic cancer in Germany and the United States.Pancreas 45, 908-914, doi:10.1097/MPA.0000000000000588 (2016).
  11. Gooiker, G. A. et al. Impact of centralization of pancreatic cancer surgery on resection rates and survival. British Journal of Surgery 101, 1000-1005, doi:10.1002/bjs.9468 (2014).
  12. Neoptolemos, J. P. et al. Low mortality following resection for pancreatic and periampullary tumours in 1026 patients: UK survey of specialist pancreatic units. UK Pancreatic Cancer Group. British Journal of Surgery 84, 1370-1376, 10.1111/j.1365-2168.1997.00504.x (1997).